Published in Biochim Biophys Acta on April 23, 2001
CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol (2006) 2.15
BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med (2008) 1.54
BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells (2013) 1.17
Defective osteogenic differentiation in the development of osteosarcoma. Sarcoma (2011) 0.98
The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte. J Biol Chem (2010) 0.89
BMP signaling in mesenchymal stem cell differentiation and bone formation. J Biomed Sci Eng (2013) 0.89
Osteogenesis of Adipose-Derived Stem Cells. Bone Res (2013) 0.84
Indian Hedgehog signalling triggers Nkx3.2 protein degradation during chondrocyte maturation. Biochem J (2012) 0.83
Wnt5a through noncanonical Wnt/JNK or Wnt/PKC signaling contributes to the differentiation of mesenchymal stem cells into type II alveolar epithelial cells in vitro. PLoS One (2014) 0.82
Molecular basis of differentiation therapy for soft tissue sarcomas. Trends Cancer Res (2016) 0.75
beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J (1997) 12.97
Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet (1998) 4.92
Female development in mammals is regulated by Wnt-4 signalling. Nature (1999) 4.13
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet (2000) 3.73
A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development (1994) 3.12
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet (2001) 2.87
Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS (1999) 2.47
[Recommendations and unanswered questions in the diagnosis and treatment of thyroid nodules. Opinion of the Thyroid Section of the German Society for Endocrinology]. Dtsch Med Wochenschr (2005) 2.45
A protein kinase encoded by the t complex responder gene causes non-mendelian inheritance. Nature (1999) 2.17
Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene (2005) 2.11
Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology (Oxford) (2008) 2.11
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut (2001) 1.97
Cloning and expression analysis of the mouse T-box gene Tbx18. Mech Dev (2001) 1.93
Brachyury is a target gene of the Wnt/beta-catenin signaling pathway. Mech Dev (2000) 1.91
Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol (1997) 1.83
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int (2000) 1.79
GDNF induces branching and increased cell proliferation in the ureter of the mouse. Dev Biol (1997) 1.56
Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet (1994) 1.53
The T genes in embryogenesis. Trends Genet (1994) 1.53
The Brachyury gene encodes a novel DNA binding protein. EMBO J (1993) 1.42
Single-step purification and h.p.l.c. analysis of glutathione transferase 8-8 in rat tissues. Biochem J (1989) 1.39
sFRP-2 is a target of the Wnt-4 signaling pathway in the developing metanephric kidney. Dev Dyn (1998) 1.37
Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) (2000) 1.35
Cloning and expression analysis of the mouse T-box gene tbx20. Mech Dev (2001) 1.28
Expression patterns of Wnt genes in mouse gut development. Mech Dev (2001) 1.27
The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr Rev (1999) 1.24
Expression of leptin and leptin receptor isoforms in the human stomach. Gut (2000) 1.22
Rescue of the tail defect of Brachyury mice. Genes Dev (1993) 1.22
Serum leptin and weight reduction in female obesity. Eur J Endocrinol (1996) 1.20
Regulation of neurotrophin-3 expression by epithelial-mesenchymal interactions: the role of Wnt factors. Science (1999) 1.19
SHH-N upregulates Sfrp2 to mediate its competitive interaction with WNT1 and WNT4 in the somitic mesoderm. Development (2000) 1.19
The paired homeobox gene Uncx4.1 specifies pedicles, transverse processes and proximal ribs of the vertebral column. Development (2000) 1.17
Cloning and expression analysis of SALL4, the murine homologue of the gene mutated in Okihiro syndrome. Cytogenet Genome Res (2002) 1.17
Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas. Endocr Relat Cancer (2010) 1.15
Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. Eur J Endocrinol (2005) 1.14
Down the tube of obstructive nephropathies: the importance of tissue interactions during ureter development. Kidney Int (2007) 1.13
Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiatr Res (1999) 1.09
Changes in cardiovascular risk factors and hormones during a comprehensive residential three month kriya yoga training and vegetarian nutrition. Acta Physiol Scand Suppl (1997) 1.09
Nephrocystin: gene expression and sequence conservation between human, mouse, and Caenorhabditis elegans. J Am Soc Nephrol (2000) 1.07
A role for Pax-1 as a mediator of notochordal signals during the dorsoventral specification of vertebrae. Development (1993) 1.07
Cyclosporin in infiltrative eye disease. Lancet (1984) 1.05
Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues. Exp Clin Endocrinol (1992) 1.00
Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest (1996) 1.00
Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction. Metabolism (1995) 1.00
Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer. J Clin Oncol (1999) 1.00
Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. J Clin Endocrinol Metab (1997) 0.99
Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin. Clin Endocrinol (Oxf) (2001) 0.98
Hypertrophy and hyperplasia during goitre growth and involution in rats--separate bioeffects of TSH and iodine. Acta Endocrinol (Copenh) (1987) 0.95
Copeptin as a marker for arginine-vasopressin/antidiuretic hormone secretion in the diagnosis of paraneoplastic syndrome of inappropriate ADH secretion. Endocrine (2013) 0.94
Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes (2004) 0.94
UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab (1997) 0.94
Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. Cancer Res (1997) 0.93
Embryonic expression of the murine homologue of SALL1, the gene mutated in Townes--Brocks syndrome. Mech Dev (2001) 0.93
Pulse amplitude and frequency modulation of parathyroid hormone in plasma. J Clin Endocrinol Metab (1989) 0.93
Genotype-phenotype correlations in PCD patients carrying DNAH5 mutations. Thorax (2003) 0.92
Induction of hyperthyroidism by interferon-alpha-2b. Lancet (1989) 0.92
Temporal patterns of alpha 1-receptor stimulation regulate amplitude and frequency of calcium transients. Am J Physiol (1993) 0.92
High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH). Ann Oncol (2011) 0.91
Time series prediction of plasma hormone concentration. Evidence for differences in predictability of parathyroid hormone secretion between osteoporotic patients and normal controls. J Clin Invest (1995) 0.91
Characterization of Pax-2 regulatory sequences that direct transgene expression in the Wolffian duct and its derivatives. Dev Biol (2001) 0.91
Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab (1987) 0.90
Hypopituitarism in a HIV affected patient. Exp Clin Endocrinol Diabetes (2011) 0.90
Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridisation and comparative genomic hybridisation. Virchows Arch (2000) 0.89
Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J Clin Endocrinol Metab (2001) 0.89
Headache and pituitary disease: a systematic review. Clin Endocrinol (Oxf) (2013) 0.88
Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology (2000) 0.88
Free leptin, bound leptin, and soluble leptin receptor in normal and diabetic pregnancies. J Clin Endocrinol Metab (1999) 0.88
Diet-induced obesity alters behavior as well as serum levels of corticosterone in F344 rats. Physiol Behav (2009) 0.87
Twenty-four-hour rhythms of plasma catecholamines and their relation to cardiovascular parameters in healthy young men. Eur J Endocrinol (1997) 0.87
Identification of novel CBFA1/RUNX2 mutations causing cleidocranial dysplasia. J Inherit Metab Dis (2001) 0.87
Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect osmoregulation but correlates with injury severity. Acta Neurochir Suppl (2010) 0.87
Menin mutations in patients with multiple endocrine neoplasia type 1. Eur J Endocrinol (1997) 0.86
Frequency and amplitude enhancement of calcium transients by cyclic AMP in hepatocytes. Biochem J (1991) 0.86
Functional and morphological changes of the thyroid gland following 5 days of pulsatile TRH stimulation in male rats. J Endocrinol (1995) 0.85
Long-term safety of growth hormone replacement after CNS irradiation. J Clin Endocrinol Metab (2011) 0.85
Hepatitis C and the leptin system: bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy. Scand J Gastroenterol (2001) 0.85
Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol (2000) 0.85
Sex steroids and body composition in men with cystic fibrosis. Eur J Endocrinol (2003) 0.85
Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells. Bone Marrow Transplant (1997) 0.85
The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol (Copenh) (1989) 0.84
L-arginine stimulates NO-dependent vasodilation in healthy humans--effect of somatostatin pretreatment. J Investig Med (1999) 0.84
Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells. Endocrinology (2001) 0.84
Molecular cloning of a functional promoter of the human plakoglobin gene. Eur J Endocrinol (2001) 0.84
Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab (1990) 0.84
Treatment of macroprolactinoma with cabergoline: a study of 85 patients. Clin Endocrinol (Oxf) (1997) 0.83
Measurement of intracellular Ca2+ in single aequorin-injected and suspensions of fura-2-loaded ROS 17/2.8 cells and normal human osteoblasts. Effect of parathyroid hormone. Biochem J (1991) 0.83
Coding efficiency and information rates in transmembrane signaling. Biosystems (2000) 0.83
Associations of anthropometric parameters with serum TSH, prolactin, IGF-I, and testosterone levels: results of the study of health in Pomerania (SHIP). Exp Clin Endocrinol Diabetes (2009) 0.83
Is there low-dimensional chaos in pulsatile secretion of parathyroid hormone in normal human subjects? Am J Physiol (1994) 0.82
Pulsatile secretion of thyrotropin during fasting: a decrease of thyrotropin pulse amplitude. J Clin Endocrinol Metab (1990) 0.82
Role of the intra-arterial calcium stimulation test in the preoperative localization of insulinomas. Eur Radiol (2000) 0.82
Hepatoma with severe non-islet cell tumor hypoglycemia. Am J Gastroenterol (1998) 0.82
A versatile chondrogenic rat calvaria cell line R-tTA-24 that permits tetracycline-regulated gene expression. Histochem Cell Biol (2000) 0.81
Incidental detection of familial medullary thyroid carcinoma by calcitonin screening for nodular thyroid disease. Eur J Endocrinol (1999) 0.81
Pax-2 regulatory sequences that direct transgene expression in the developing neural plate and external granule cell layer of the cerebellum. Brain Res Dev Brain Res (1999) 0.81
One injection of platelet-rich plasma associated to a submaximal eccentric protocol to treat chronic jumper's knee. J Sports Med Phys Fitness (2014) 0.81
Alterations of cognitive functions induced by exogenous application of thyroid hormones in healthy men: a double-blind cross-over study using event-related brain potentials. Thyroid (2001) 0.81
Quality of life in patients with Addison's disease: effects of different cortisol replacement modes. Exp Clin Endocrinol (1993) 0.81
Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome. J Clin Endocrinol Metab (2014) 0.81